Peter Lamb, EVP, Scientific Strategy & CSO at EXELIXIS, INC. (EXEL), sold 99,646 shares at $17.44 ($1.7M) on 2021-12-15, disclosed to the SEC on 2021-12-17.
Open-market sale of $1.7M EXEL by EVP, Scientific Strategy & CSO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.00 | 4,646 | $79K | 4.6% |
| 2 | $17.44 | 47,500 | $828K | 47.7% |
| 3 | $17.44 | 47,500 | $828K | 47.7% |
| Total | $17.42 avg | 99,646 | $1.7M | 100% |
| Filing → |
| EXEL | SELL | 2021-10-15 | $2.1M | — | Filing → |
| EXEL | SELL | 2021-09-17 | $972K | — | Filing → |
| EXEL | SELL | 2021-08-18 | $2.0M | — | Filing → |